Related by context. All words. (Click for frequent words.) 75 bevacizumab Avastin 75 sorafenib Nexavar 74 ImClone Erbitux 74 Ixempra 74 lapatinib Tykerb 74 Erbitux cetuximab 74 Nexavar sorafenib 74 BRAF inhibitor 73 Taxol paclitaxel 73 gefitinib Iressa 73 erlotinib Tarceva 73 AVASTIN 73 ixabepilone 72 Aflibercept 72 cediranib 72 Vidaza azacitidine 72 pertuzumab 72 Taxotere docetaxel 72 Erlotinib 72 Pemetrexed 72 etanercept Enbrel 72 thalidomide Thalomid 72 cetuximab Erbitux R 72 iniparib 72 Sprycel dasatinib 72 enzastaurin 71 Amrubicin 71 adalimumab Humira 71 IL# PE#QQR 71 Avastin bevacizumab 71 metastatic castration resistant 71 cetuximab Erbitux ® 71 docetaxel Taxotere R 71 Femara letrozole 71 dasatinib Sprycel 71 Velcade bortezomib 71 sunitinib Sutent 71 metastatic colorectal 71 Zolinza 71 panitumumab Vectibix 71 Cetuximab Erbitux 71 malignant ascites 71 Pivotal Phase III 71 Vectibix panitumumab 71 Bevacizumab 71 Targretin 71 Gleevec imatinib mesylate 71 docetaxel Taxotere ® 71 Zarnestra 71 sorafenib tablets 71 Bayer Nexavar 71 Gleevec imatinib 70 Herceptin trastuzumab 70 Xelox 70 olaparib 70 Taxotere chemotherapy 70 paclitaxel Taxol 70 MyVax R 70 Tocosol Paclitaxel 70 evaluating tivozanib 70 mapatumumab 70 trastuzumab DM1 70 Pfizer Sutent 70 Nexavar ® 70 Panitumumab 70 Bevacizumab Avastin 70 HuMax EGFr 70 imatinib Gleevec 70 Crizotinib 70 Neuvenge 70 axitinib 70 Jevtana 70 interferon gamma 1b 70 MAGE A3 ASCI 70 Temsirolimus 70 Genentech Rituxan 70 Safinamide 70 ZOLINZA 70 Vandetanib 70 Gemzar ® 70 oxaliplatin Eloxatin 70 bortezomib Velcade 70 gemcitabine chemotherapy 70 Arimidex anastrozole 70 bevacizumab Avastin ® 70 pegylated liposomal doxorubicin 70 Merck KGaA Erbitux 69 hormone refractory metastatic prostate 69 sunitinib malate 69 Torisel 69 alkylating agent 69 Zybrestat 69 Vidaza R 69 gemcitabine Gemzar 69 forodesine 69 dasatinib 69 FOLFOX6 69 Revlimid lenalidomide 69 standard chemotherapy regimen 69 Roche Herceptin 69 vandetanib 69 5 fluorouracil leucovorin 69 Romiplostim 69 ZACTIMA 69 Alimta pemetrexed 69 Torisel temsirolimus 69 Canvaxin 69 Ceflatonin 69 Omnitarg 69 Campath alemtuzumab 69 Taxotere ® 69 galiximab 69 lumiliximab 69 temsirolimus 69 Bonefos 69 Aplidin 69 Camptosar ® 69 efaproxiral 69 gastrointestinal stromal tumors GIST 69 metastatic malignant 69 neratinib 69 huC# DM4 69 TLK# 69 L BLP# 69 Gemzar gemcitabine 69 Fludara ® 69 Hormone Refractory Prostate Cancer 69 angiogenesis inhibitor 69 abatacept Orencia 69 vidofludimus 69 Ambrisentan 69 midstage clinical 69 anastrozole Arimidex 69 Tarceva TM 69 oral ridaforolimus 68 phase IIb trial 68 Degarelix 68 virus HCV protease inhibitor 68 erlotinib Tarceva ® 68 Vicriviroc 68 AstraZeneca Iressa 68 corticosteroid dexamethasone 68 FOLOTYN ® 68 YONDELIS 68 metastatic castrate resistant 68 Hycamtin 68 antibody MAb 68 Rituxan rituximab 68 infusional 5-FU/LV 68 oral prodrug 68 Pertuzumab 68 Combination REOLYSIN R 68 Achieves Primary Endpoint 68 pan HDAC inhibitor 68 deforolimus 68 Tarceva erlotinib 68 exemestane Aromasin 68 Votrient 68 Roche Xeloda 68 Brentuximab Vedotin SGN 68 Irinotecan 68 Dasatinib 68 Mipomersen 68 Sutent sunitinib 68 Novantrone 68 trastuzumab Herceptin 68 Doxil ® 68 oral deforolimus 68 DU #b 68 elotuzumab 68 Riluzole 68 midstage studies 68 phase IIb clinical 68 5 Fluorouracil 68 metaglidasen 68 radiation sensitizer 68 pemetrexed Alimta 68 midstage trials 68 aflibercept 68 tamoxifen citrate 68 Panzem NCD 68 RSR# 68 PTK# 68 Mitoxantrone 68 Xeloda capecitabine 68 Temodar temozolomide 68 sitaxsentan 68 Navelbine ® 68 atrasentan 68 Clolar ® 68 Trastuzumab 67 docetaxel chemotherapy 67 Aliskiren 67 Copegus ribavirin 67 zoledronic acid Zometa 67 Glaxo Tykerb 67 amifostine 67 Soriatane 67 alvespimycin 67 generation purine nucleoside 67 Golimumab 67 Noxafil 67 Abiraterone acetate 67 Sanofi Aventis Taxotere 67 SPRYCEL ® 67 Ixabepilone 67 Sorafenib 67 proteasome inhibitor 67 docetaxel Taxotere 67 motesanib 67 Romidepsin 67 Meets Primary Endpoint 67 FASLODEX 67 cabazitaxel 67 Orally administered 67 Pirfenidone 67 mTOR inhibitor 67 GW# [003] 67 ELACYT 67 investigational humanized monoclonal antibody 67 Peginterferon alfa 2b 67 pediatric acute lymphoblastic 67 rituximab Rituxan 67 Tykerb lapatinib 67 Rebif ® 67 IgG1 monoclonal antibody 67 R sorafenib tablets 67 recurrent glioblastoma multiforme 67 investigational monoclonal antibody 67 Caelyx 67 HGS ETR2 67 Adentri 67 Gemcitabine 67 Roche Pegasys 67 canagliflozin 67 ZD# [001] 67 PTK ZK 67 IMA# 67 prostate cancer mCRPC 67 reslizumab 67 LymphoStat B TM 67 Zorbtive TM 67 imatinib Gleevec ® 67 Humira adalimumab 67 HER2 positive metastatic breast 67 Lenalidomide 67 anticancer compound 67 Fablyn 67 Inhalation Solution 67 Anastrozole 67 Muraglitazar 67 relapsed ovarian cancer 67 infliximab Remicade 67 Cabazitaxel 67 Abacavir 67 Everolimus 67 HuMax CD# 67 MKC# MT 67 5 FU leucovorin 67 Temodar ® 67 BRIM2 67 alefacept 67 Luveris 67 adjuvant colon cancer 67 multiple myeloma MM 67 EGFR inhibitors 67 LY# [003] 67 Gleevec Glivec 67 LAF# 67 Pegintron 67 alpha interferons 67 capecitabine Xeloda 67 Tasigna nilotinib 67 Elagolix 67 Seliciclib 67 INCB# [003] 67 TBC# 67 PEGylated Fab fragment 67 Exemestane 67 carboplatin paclitaxel 67 Xeloda ® 67 receptor tyrosine kinase inhibitor 67 anthracycline taxane 67 Troxatyl 67 Cimzia TM 67 CIMZIA TM certolizumab pegol 67 Aptivus ® 67 Factor Xa inhibitor 67 pediatric malignancies 66 Actimmune ® 66 Interferon beta 1b 66 Panzem 66 bosutinib 66 glufosfamide 66 chemopreventive agent 66 Corlux 66 ribavirin USP 66 GlaxoSmithKline Tykerb 66 BAY #-# 66 Azacitidine 66 Boceprevir 66 gemcitabine Gemzar R 66 nilotinib Tasigna 66 Telcyta 66 Sutent sunitinib malate 66 Oxaliplatin 66 PEG SN# 66 Phase IIb clinical trials 66 lenalidomide Revlimid R 66 refractory chronic lymphocytic 66 ThermoDox R 66 Adjuvant Treatment 66 EGFR TKI 66 Neulasta ® 66 Faslodex 66 alendronate Fosamax 66 Arcalyst 66 Panzem R NCD 66 MGd 66 Denufosol 66 dasatinib Sprycel ® 66 ARIMIDEX 66 Crestor rosuvastatin 66 Remicade infliximab 66 idraparinux 66 Dendreon Provenge 66 nilotinib 66 assessing T DM1 66 UPLYSO 66 ASA# 66 trastuzumab Herceptin R 66 Folotyn 66 Eltrombopag 66 metastatic hormone refractory 66 temozolomide Temodar 66 Genasense ® 66 CYT# potent vascular disrupting 66 Neoadjuvant 66 irinotecan chemotherapy 66 clodronate 66 non metastatic osteosarcoma 66 Viramidine 66 Enbrel etanercept 66 Atrasentan 66 AMEVIVE 66 Cinquil 66 liposomal amphotericin B 66 HuMax CD4 66 PF # [002] 66 metastatic kidney 66 Promacta 66 Xinlay 66 Theratope 66 edifoligide 66 Mepact 66 Presents Preclinical 66 Xanafide 66 baminercept 66 paclitaxel Taxol ® 66 endometrial hyperplasia 66 everolimus Afinitor 66 eltrombopag 66 AVE# 66 luteinizing hormone releasing 66 XYOTAX TM 66 ACTEMRA TM 66 Bayer Onyx 66 Completes Patient Enrollment 66 Cloretazine ® 66 Topotecan 66 BARACLUDE ® 66 Onconase 66 Zometa zoledronic acid 66 tenofovir emtricitabine 66 Gefitinib 66 Taxotere R 66 humanised monoclonal antibody 66 OvaRex ® MAb 66 Combination therapy 66 Paraplatin ® 66 Deforolimus 66 tremelimumab 66 Tezampanel 66 FOLFOX chemotherapy 66 trabectedin 66 Initiates Phase III 66 Paraplatin 66 NV1FGF 66 Celgene Revlimid 66 Removab 66 GRN# 66 mRCC 66 ProSavin 66 AEG# 66 anti angiogenic agent 66 Epratuzumab 66 trastuzumab DM1 T DM1 66 verteporfin 66 fostamatinib 66 Zytiga 66 Egrifta 66 Lapatinib 66 mitoxantrone plus 66 Pivotal Phase 66 Allovectin 7 66 Leukine 66 gemcitabine carboplatin 66 lung pancreatic 66 SAR# [004] 66 MyVax 66 selective modulator 66 Vidaza ® 66 Fulvestrant 66 mertansine 66 abiraterone 66 Hepatocellular Carcinoma HCC 66 PegIntron 66 eniluracil 66 Annamycin 66 tyrosine kinase inhibitor 66 Phase #b/#a clinical 66 R lenalidomide 66 paroxetine Paxil 66 terlipressin 66 Trandolapril 66 recurrent metastatic 66 refractory gout 66 oral salmon calcitonin 66 non resectable metastatic 66 SinuNase TM 66 cell lymphoma CTCL 65 midstage clinical trials 65 pazopanib 65 paclitaxel Taxol R 65 Bisphosphonate 65 Potiga 65 entinostat 65 regorafenib 65 Fludara 65 unresectable tumors 65 Alemtuzumab 65 estramustine 65 Randomized Phase 65 thetreatment 65 Vitaxin 65 ocrelizumab 65 Darusentan 65 Investigational Compound 65 aripiprazole Abilify 65 Arranon 65 efalizumab 65 ritonavir boosted 65 cardiotoxic 65 fulvestrant 65 flutamide 65 zalutumumab 65 Phase IIIb clinical 65 STELARA TM 65 Folfox 65 pegylated interferons 65 letrozole Femara 65 BRIM3 65 Novartis Afinitor 65 Gliadel Wafer 65 PKC# 65 canakinumab 65 IRESSA 65 vemurafenib 65 Factor VIIa 65 leukemia AML 65 TNF Tumor Necrosis Factor 65 tafamidis 65 blood thinner Xarelto 65 relapsed ALL 65 teriflunomide 65 metastatic renal cell carcinoma 65 rasagiline tablets 65 Proxinium TM 65 Quinamed 65 goserelin 65 Thalomid thalidomide 65 ganetespib 65 refractory metastatic colorectal cancer 65 vinflunine 65 IV Busulfex 65 Phase 2b Clinical Trial 65 phase IIb 65 eritoran 65 Cetuximab 65 Bristol Myers Squibb Sprycel 65 Personalized Immunotherapy 65 KRN# 65 FOLFOX4 65 iclaprim 65 APPRAISE 65 Yervoy 65 Capecitabine 65 Zoledronic acid 65 Pazopanib 65 Abiraterone 65 trastuzumab Herceptin ® 65 rNAPc2 65 INCB# [001] 65 methylnaltrexone bromide 65 xanthine oxidase inhibitor 65 Hodgkin lymphoma HL 65 ranibizumab Lucentis 65 glatiramer 65 Onyx Pharmaceuticals Inc 65 beta 1a 65 Cladribine 65 Advexin 65 AstraZeneca Arimidex 65 FOLFOX6 chemotherapy regimen 65 SNT MC# 65 OPAXIO 65 PANVAC VF 65 bladder ovarian 65 Cloretazine 65 metastatic renal cell 65 Alkeran 65 sunitinib 65 Novartis Gleevec 65 phase IIb study 65 Phase IIb Trial 65 antibody MT# 65 Immunotherapeutic 65 Paxil paroxetine 65 Tanespimycin 65 eflornithine 65 Phase IIb trials 65 IMC A# 65 vorinostat 65 BARACLUDE R 65 SERMs 65 R Saizen R 65 5-FU/LV 65 K ras mutations 65 Genentech Herceptin 65 OSI Tarceva 65 Ophena TM 65 metastatic carcinoma 65 fluvastatin 65 TELINTRA 65 Fluconazole 65 CoFactor 65 Nexavar tablets 65 recurrent glioblastoma 65 pomalidomide 65 Afatinib 65 orBec 65 trial evaluating PRX# 65 elagolix 65 raloxifene Evista 65 GVAX 65 bortezomib Velcade ® 65 incyclinide 65 CDP# 65 Losartan 65 Phase #/#a trial 65 Fondaparinux 65 Amgen Vectibix 65 Initiate Phase 65 investigational antiplatelet agent 65 Genasense ® oblimersen 65 cancer mCRC 65 mycophenolate mofetil 65 Sudhir Agrawal D.Phil 65 KRAS status 65 Myelodysplastic Syndrome MDS 65 lenalidomide dexamethasone 65 Diovan HCT 65 zanolimumab 65 KRAS mutation 65 Hycamtin ® 65 Starlix 65 Taxol ® 65 Cancidas 65 QVA# 65 Initiates Enrollment 65 Carvedilol 65 aflibercept VEGF Trap 65 darapladib 65 histone deacetylase HDAC inhibitor 65 visilizumab 65 PSN# [002] 65 Arixtra 65 Enzastaurin 65 cilengitide 65 Aromasin 65 TO AVOID PREGNANCY WHILE 65 dopamine receptor agonist 65 Toremifene 65 Asentar 65 CINTREDEKIN BESUDOTOX 65 microtubule inhibitor 65 RoACTEMRA 65 solanezumab 65 anticancer therapy 65 Ozarelix 65 fosbretabulin 65 taxane chemotherapy 65 OHR/AVR# 65 receptor modulators 64 immunotherapeutic agent 64 Patients Treated With 64 Reverset 64 T DM1 64 HGS ETR1 64 amrubicin 64 tanespimycin 64 severe hypercholesterolemia 64 mycophenolic acid 64 decitabine 64 Pivotal Clinical Trial 64 p# MAP kinase inhibitor 64 crizotinib PF # 64 bexarotene 64 Tavocept 64 Gleevec resistant 64 Novel Oral 64 Pralatrexate 64 invasive candidiasis 64 PDX pralatrexate 64 LHRH receptor positive 64 Evoltra ® 64 CANCIDAS 64 FOLFIRI 64 Bazedoxifene 64 anidulafungin 64 Eribulin 64 dexamethasone Decadron 64 EndoTAGTM 1 64 IAP inhibitors 64 OvaRex 64 Prilosec omeprazole 64 EOquin TM 64 Friedreich Ataxia FRDA 64 Vaprisol 64 Initiate Clinical Trial 64 Epivir 64 drug Treanda 64 Pyridorin 64 dexpramipexole 64 Roche Chugai s 64 plus gemcitabine 64 complete cytogenetic response 64 REYATAZ R 64 induced macular edema 64 tenofovir Viread 64 esophageal candidiasis 64 diagnostic biomarker 64 Celebrex celecoxib 64 phase IIb III 64 Xyotax 64 Laquinimod 64 bazedoxifene 64 custirsen 64 Sapacitabine 64 Telintra 64 novel VDA molecule 64 Daclizumab 64 paclitaxel carboplatin 64 LymphoStat B belimumab 64 Treanda 64 lymphoid malignancies 64 chemotherapy cisplatin 64 Archexin 64 lexidronam injection 64 ToGA 64 HoFH 64 ADP receptor antagonist 64 Eculizumab 64 Dapagliflozin 64 antihormonal 64 Squalamine 64 ospemifene 64 Fludarabine 64 Orencia abatacept 64 randomized Phase IIb 64 Tocilizumab 64 plus dexamethasone 64 Phenoptin 64 Phase 2b Study 64 monoclonal antibody conjugated 64 Pegylated Interferon 64 HER2 amplified 64 IMC #B 64 candesartan cilexetil 64 Her2 positive 64 systemic ALCL 64 Genentech Roche 64 COREG 64 ORENCIA ® 64 JAK inhibitor 64 posaconazole 64 dual endothelin receptor antagonist 64 Civacir 64 mTOR inhibitors 64 FOLFIRI chemotherapy 64 Carfilzomib 64 abacavir Ziagen 64 VNP#M 64 PRT# 64 olmesartan 64 Mylotarg 64 NS#/#A protease 64 seliciclib 64 Xcytrin R 64 liposomal formulation 64 TORISEL 64 Roche Actemra 64 Bicalutamide 64 Kepivance 64 demethylating agent 64 idebenone 64 Proquin XR 64 YONDELIS R 64 Mycamine 64 evaluating picoplatin 64 rosuvastatin Crestor 64 LEP ETU 64 Aviptadil 64 Epirubicin 64 LymphoStat B 64 BR.# 64 AZILECT R 64 beta interferons 64 MetMAb 64 eosinophilic asthma 64 LBH# 64 multi kinase inhibitor 64 Ocrelizumab 64 Telbivudine 64 Dacogen decitabine 64 Adenoma Prevention 64 Modrenal R 64 mutated KRAS gene 64 Calcitonin 64 Intravitreal 64 acetonide FA 64 brivanib 64 Motavizumab 64 uric acid lowering 64 capecitabine Xeloda R 64 imatinib mesylate Gleevec 64 LSE ASM 64 nonsmall cell lung cancer 64 Doxil 64 cisplatin vinorelbine 64 myelodysplastic myeloproliferative diseases 64 Pivotal Trial 64 liposomal doxorubicin 64 Tasimelteon 64 Bortezomib 64 small molecule tyrosine 64 resistant hormone refractory 64 ABX EGF 64 TNF blocker 64 sodium thiosulfate STS 64 HRPC 64 tyrosine kinase inhibitors TKIs 64 lamotrigine Lamictal 64 oral anticancer 64 Trastuzumab DM1 64 refractory CTCL 64 topotecan 64 metastatic CRC 64 pharmacokinetic PK study 64 alfa 2a 64 leuprorelin 64 TroVax ® 64 OMP #M# 64 hormone LHRH antagonist 64 pain palliation 64 TASKi3 64 Kaletra lopinavir ritonavir 64 nab paclitaxel 64 PSMA ADC 64 FUSILEV enhances 64 DOXIL 64 colorectal lung 64 Eli Lilly Gemzar 64 Roche Avastin 64 whose tumors overexpress 64 Vectibix 64 Omapro 64 alemtuzumab Campath 64 Panzem R 64 sargramostim 64 AMN# [001] 64 OMP #R# 64 HuLuc# 64 SCCHN 64 nucleotide analogue 64 Silodosin 64 Cytoxan 64 ibandronate 64 Prestara 64 leukemia ALL 64 dacarbazine chemotherapy 64 idiopathic thrombocytopenic purpura ITP 64 NSABP C 64 Dabigatran 64 Simponi golimumab 64 PNP inhibitor 64 depsipeptide 64 BRAF mutant 64 THALOMID R 64 PEGylated anti 64 Cellcept 64 fallopian tube cancers 64 Hsp# Inhibitor 64 angiotensin II receptor blocker 64 CR# vcMMAE 64 sulindac 64 compound AEZS 64 pancreatic neuroendocrine tumors 64 basiliximab 64 AEGR 64 CBLC# 64 OPAXIO TM 64 irinotecan oxaliplatin 64 Zemplar 64 QLT# 64 Ethyol 64 post menopausal osteoporosis 64 Leukine ® 64 Interferon beta 1a 64 trabedersen 64 Abraxane 64 riociguat 64 finasteride Proscar 64 TTF Therapy 64 SUTENT ® 64 VFEND 64 OncoVEX GM CSF 64 TOCOSOL 64 pregabalin Lyrica 64 nucleoside analog 64 gastrointestinal stromal tumors 64 refractory acute myeloid 64 Eloxatin ® 64 DPP4 64 talabostat 64 FUSILEV ® 64 Maraviroc 64 systemically administered 64 Vertex telaprevir 64 AZILECT ® 64 mGluR5 negative 64 abiraterone acetate 63 Naive Patients 63 multicenter Phase II 63 relapsed MM 63 pan histone deacetylase 63 renal toxicity 63 myelofibrosis polycythemia vera 63 Novartis Reclast 63 Vincristine 63 ovarian breast 63 chlorambucil 63 Capesaris 63 interferon ribavirin 63 metastatic gastric 63 Atacand 63 omacetaxine mepesuccinate 63 immunosuppressant drug 63 Catena ® 63 Procoralan 63 cytotoxic therapy 63 nicardipine 63 vascular disrupting agents 63 acute peripheral arterial 63 biologic therapy 63 HSP# inhibitor 63 cinacalcet 63 sorafenib 63 anti angiogenic agents 63 CYC# 63 ErbB2 positive 63 Tocosol 63 Aryplase 63 Peginterferon 63 Zoloft sertraline 63 investigational hepatitis C 63 Telmisartan 63 ELIQUIS 63 psoriasis rheumatoid arthritis 63 evaluating T DM1 63 BRCA deficient 63 phase III isavuconazole 63 Interferon alpha 63 Pegloticase 63 Receives Orphan Drug Designation 63 pegfilgrastim 63 Iressa gefitinib 63 levosimendan 63 Bosentan 63 Oncogenex 63 tarenflurbil 63 fluorouracil leucovorin 63 Alteplase 63 Complicated Skin 63 Amplimexon 63 Advagraf 63 figitumumab 63 Refractory Hodgkin Lymphoma 63 gastrointestinal stromal tumors GISTs 63 sipuleucel T 63 chimeric monoclonal antibody 63 PXD# 63 Known generically 63 octreotide LAR 63 PROSTVAC TM 63 ORAL Sync 63 ongoing Phase 1b 63 Phase III Trial 63 ponatinib 63 Fluorouracil 63 Fibrillex 63 pegylated interferon alpha 63 cMET 63 Rilutek 63 TEMODAL 63 chemotherapeutic agent 63 TELCYTA 63 ralfinamide 63 Neupro R 63 Onrigin 63 Phase III Clinical Trial 63 pemetrexed 63 Epidermal Growth Factor Receptor 63 salmeterol fluticasone 63 intravenous bisphosphonates 63 tinidazole 63 Vitrasert R 63 antimetabolite 63 sertraline Zoloft 63 ELOXATIN 63 hepatocellular cancer 63 oral Xeloda 63 histone deacetylase inhibitor 63 investigational oral hepatitis C 63 CTAP# Capsules 63 dihydrochloride 63 MEK Inhibitor 63 inhibitor RG# 63 TORISEL TM 63 acyclovir Lauriad R 63 mCRC patients 63 chemosensitizer 63 Pulminiq 63 arzoxifene 63 Azedra 63 anakinra 63 bevacizumab Avastin R 63 atacicept 63 homozygous familial hypercholesterolemia 63 metastatic sarcomas 63 Elotuzumab 63 vismodegib 63 grade serous ovarian 63 Cetrorelix 63 targeted radiotherapeutic 63 Tacrolimus 63 Cyclosporin 63 adriamycin 63 paclitaxel cisplatin 63 Halaven 63 CAELYX 63 antiangiogenic therapy 63 tipifarnib 63 brivaracetam 63 anti EGFR antibody 63 CDK inhibitor 63 antiarrhythmic 63 RNAi therapeutic targeting PCSK9 63 Galantamine 63 tocilizumab 63 fluvastatin Lescol 63 adenosine injection 63 catheter occlusion 63 Initiates Phase II 63 pamidronate 63 IRX 2 63 phase IIa 63 palliative radiotherapy 63 comparator arm 63 clopidogrel Plavix 63 systemic anaplastic large 63 SU# [003] 63 anthracyclines taxanes 63 velafermin 63 Fingolimod 63 Seattle Genetics SGEN 63 Reolysin 63 Casodex 63 omega interferon